Methylprednisolone With Endovascular Thrombectomy for Large Ischemic Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1614 participants.

Also called NCT06870448

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,614 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06870448
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06870448. Randomized; quadruple masking; primary purpose treatment. Start 2025-04 (anticipated); primary completion 2029-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Methylprednisolone With Endovascular Thrombectomy for Large Ischemic Stroke
Acronym
MATCH
Condition
Acute Ischemic Stroke
Intervention (Drug)
Methyprednisolone sodium succinate
Intervention (Drug)
Placebo
Lead sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (class: other)

Record details

Record id
cardio:ct-nct06870448
Content hash
660c812bab9b4e4c181b6f9500bf74fe930c67b627d3fea02c27a722c00aadd5